ArticleBMC psychiatry2026
Unraveling the genetic interplay and therapeutic potentials between major depressive disorder and metabolic syndrome: multi-ancestry and multi-trait genome-wide association analyses.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This investigation elucidates the genetic connection between major depressive disorder (MDD) and metabolic syndrome (MetS), suggesting bidirectional genetic correlations and shared pleiotropic genes. Leveraging a comprehensive genome-wide association study (GWAS) dataset from European and East Asian populations, we discovered new genetic markers linked to MDD and enhanced the robustness of genetic associations via cross-trait analysis. Moreover, the study harnessed computational strategies for drug repurposing, identifying Cytochrome P450 and HDAC inhibitors as candidate drugs for further investigation in MDD and MetS. Employing BLISS technology, we pinpointed proteins significantly linked to both conditions, advancing our comprehension of their molecular underpinnings. Through Mendelian randomization, we investigated how diverse dietary patterns across populations influence MDD and MetS, shedding light on the relationship between diet and disease susceptibility. This research not only enriches our understanding of the intersecting biological pathways of MDD and MetS but also opens avenues for innovative preventive and therapeutic measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.